IL17A and psoriasis: However, pathways involved in interleukin-17 (IL-17) signaling, including “Role of IL-17A in Psoriasis”, “IL-17A Signaling in Gastric Cells”, and “IL-17 Signaling” were predicted to be inhibited (Figure 3A).